APR 07, 2020 7:37 AM PDT

Computers Predict Diabetes with 94.9 Percent Accuracy

WRITTEN BY: Tara Fernandez

"Currently we do not have sufficient methods for predicting which generally healthy individuals will develop diabetes," says Akihiro Nomura of Kanazawa University, author of a new study that used artificial intelligence (AI) as a clinical tool to predict diabetes.

Diabetes mellitus is a chronic condition that affects how the body metabolizes glucose. Patients with Type 1 and Type 2 diabetes have too much sugar in their blood, a condition that can result in serious health complications. A CDC report estimates that over 100 million Americans have either diabetes or prediabetes. However, the problem, as Nomura points out, is that healthcare providers do not have a good way of foreseeing who to focus clinical and lifestyle interventions on to prevent the future onset of diabetes — until now.

Machine learning is a type of AI in which computers can “learn”, without programming, to make connections out of large datasets. Making sense of massive amounts of data is often too complicated and overwhelming for the human brain to achieve. Additionally, machine learning systems get “smarter” as they are exposed to more data, creating an ever-evolving system that is better equipped at recognizing subtle patterns. In this study, the researchers fed the computer system over half a million health checkup records from over 139,000 participants over a decade. About half of these individuals did not have diabetes, while around 5,000 did go on to be diagnosed with the disease.

According to Nomura, "Using machine learning, it could be possible to precisely identify high-risk groups of future diabetes patients better than using existing risk scores." 

"In addition, the rate of visits to healthcare providers might be improved to prevent the future onset of diabetes." Impressively, the machine learning system predicted the future development of diabetes with an accuracy of 94.9 percent.

 

 

The researchers’ next steps involve clinical trials to assess the robustness of the system among larger cohorts and how pharmaceutical interventions such as statin treatment can change patient outcomes.

 


Sources: Medical XPress, Journal of the Endocrine Society.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 14, 2020
Clinical & Molecular DX
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
JUL 14, 2020
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
A study published in the journal Nature provides new evidence supporting an unconventional test to map recovery paths of ...
JUL 22, 2020
Clinical & Molecular DX
Unmasking the Secrets of the Substantia Nigra to Diagnose Parkinson's
JUL 22, 2020
Unmasking the Secrets of the Substantia Nigra to Diagnose Parkinson's
Parkinson’s disease is a devastating condition whereby neurons in a specific region of the brain that controls mov ...
AUG 06, 2020
Cardiology
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
AUG 06, 2020
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
Strokes are life-changing events that can cause a myriad of issues even after it is over. Plenty of tests, such as the n ...
AUG 16, 2020
Microbiology
Newly Discovered Gut Enzyme Could Function as Disease Biomarker
AUG 16, 2020
Newly Discovered Gut Enzyme Could Function as Disease Biomarker
Bacteria in the gut have a powerful influence on our health, in part because all of those microbes have genes of their o ...
SEP 02, 2020
Clinical & Molecular DX
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
SEP 02, 2020
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
Yawning in the middle of the day is completely normal for people with hectic schedules. How do you know whether it&rsquo ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
Loading Comments...